There’s a great debate these days about what the current crop of AI chatbots should and shouldn’t do for you. We aren’t wise enough to know the answer, but we were interested in ...

One is among the most influential songwriters of all time, the other inspired a viral ear worm described as “Neil Diamond-lite.” After a brief discussion about the “through line” of several of her ...

What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Tim Mulkerin is a freelance writer, editor, and social media manager who has been working in digital media and the tech world since 2016. He has a bachelor's degree in art history and is currently ...

Doing the work of an educator is tiring. Doing it right is even more tiring. A few months ago, I felt this degree of exhaustion before returning from winter break. It was the Friday before we were ...

Joy Behar opened up about her weight-loss journey, revealing she lost 25 pounds with the help of a GLP-1 medication. On a recent episode of The View, the co-hosts discussed their personal experiences ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Scientists have taken a major step toward mimicking nature’s tiniest gateways by creating ultra-small pores that rival the dimensions of biological ion channels—just a few atoms wide. The breakthrough ...